Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Rapid Identification of UCA1 as a Very Sensitive and Specific Unique Marker for Human Bladder Carcinoma
2006
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Rapid Induction of Lung Adenocarcinoma by Fibroblast Growth Factor 9 Signaling through FGF Receptor 3
2013
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland.
1998
Untangling the ErbB signalling network
2001 Standout
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Breast cancer
2019 Standout
Targeted Therapy in Breast Cancer
2004
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy
2003
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
2002 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Microsatellite instability in colorectal cancer—the stable evidence
2010
Current clinical outcomes demand new treatment options for SCCHN
2005
Urine markers for detection and surveillance of bladder cancer
2013
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
Oncogenic kinase signalling
2001 StandoutNature
Altered fractionation and combined radio-chemotherapy approaches
2003
Head and neck cancer
2008 Standout
Multiple Synostoses Syndrome Is Due to a Missense Mutation in Exon 2 of FGF9 Gene
2009
Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms
2004
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients
2000
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer
2007
Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer
2008
Global cancer statistics
2011 Standout
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers
2017
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Perfusion CT: Noninvasive Surrogate Marker for Stratification of Pancreatic Cancer Response to Concurrent Chemo- and Radiation Therapy
2008
DDT/DDE and breast cancer: A meta-analysis
2013
Bladder cancer biomarkers: current developments and future implementation
2007
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010
2011
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Bladder cancer
2016 Standout
The pathobiology of mucositis
2004 Standout
Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma
2017
Epidemiology — identifying the causes and preventability of cancer?
2005
Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases
2007
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Oxidative Stress in Cancer
2020 Standout
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Time factor in postoperative radiotherapy: A multivariate locoregional control analysis in 868 patients
2003
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
2011
Molecular pathology of the fibroblast growth factor family
2009
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
A microRNA polycistron as a potential human oncogene
2005 StandoutNature
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma
2013
Organochlorine pesticides and endometriosis
2010
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Breast cancer metastasis: markers and models
2005 Standout
Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention
2009
Bisphenol A-associated epigenomic changes in prepubescent girls: a cross-sectional study in Gharbiah, Egypt
2013
The Fibroblast Growth Factor signaling pathway
2015 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
2005 Standout
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
γ‐Synuclein and the progression of cancer
2007
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse
2001
Head and Neck Cancer
2020 Standout
Time-trend in epidemiological and pathological features of schistosoma-associated bladder cancer.
2008
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
2005 Standout
Ratiometric Fluorescent Biosensor for Hyaluronidase with Hyaluronan As Both Nanoparticle Scaffold and Substrate for Enzymatic Reaction
2014
Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity
2015
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
2009
Organochlorine Pesticides and Risk of Endometriosis: Findings from a Population-Based Case–Control Study
2013
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
The MicroRNA Spectrum in 12 Body Fluids
2010 Standout
Role of HER2 gene overexpression in breast carcinoma
2000
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Reactive oxygen signaling and MAPK activation distinguish Epstein–Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma
2004
Global cancer statistics, 2012
2015 Standout
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Oral Sequelae of Head and Neck Radiotherapy
2003 Standout
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Works of Sanaa Eissa being referenced
Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
1997
Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation
2002
Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients
2001
Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
2002
Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
1997
Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
1997
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma
2008
Direct detection of hyaluronidase in urine using cationic gold nanoparticles: A potential diagnostic test for bladder cancer
2013
High levels of oxidative DNA damage in lymphocyte DNA of premenopausal breast cancer patients from Egypt
2004
Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
2007
Serum organochlorine levels and history of lactation in Egypt
2003
Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC)
2000
Genomic imbalances in Schistosoma-associated and non–Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis
2007
Regulators of apoptosis in human breast cancer
1999
Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma
2004
SomaticFGF9mutations in colorectal and endometrial carcinomas associated with membranousβ-catenin
2007
DNA Copy Number Changes in Schistosoma-Associated and Non-Schistosoma-Associated Bladder Cancer
2000
Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs
2005
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder
2006
Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay
2015
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in E gypt and T unisia
2013
Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions.
1997
Diagnostic value of urinary molecular markers in bladder cancer.
2003
Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients
2001
Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis
2015
Breast cancer in Egypt:a review of disease presentation and detection strategies
2021